Comparative coronary risks of apixaban rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

机译：阿哌沙班利伐沙班和达比加群的比较冠心病风险：一项荟萃分析和调整后的间接比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsThere are concerns regarding increased risk of acute coronary syndrome with dabigatran. We aimed to assess whether alternative treatment options such as rivaroxaban or apixaban carry a similar risk as compared with dabigatran.

机译：目的有人担心达比加群会增加急性冠状动脉综合征的风险。我们旨在评估与达比加群相比，利伐沙班或阿哌沙班等替代疗法是否具有相似的风险。

著录项

期刊名称 British Journal of Clinical Pharmacology
作者
Yoon K Loke; Shiva Pradhan; Jessica Ka-yan Yeong; Chun Shing Kwok;
展开▼
作者单位

展开▼
年(卷),期 2014(78),4
年度 2014
页码 707–717
总页数 11
原文格式 PDF
正文语种
中图分类药学;
关键词
acute coronary syndrome apixaban dabigatran rivaroxaban;

机译：急性冠脉综合征;阿哌沙班;达比加群;利伐沙班;

相似文献

外文文献
中文文献
专利

1. Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison [J] . Loke Yoon K., Pradhan Shiva, Yeong Jessica Ka-yan, British Journal of Clinical Pharmacology . 2014,第4期

机译：阿哌沙班，利伐沙班和达比加群的比较冠心病风险：一项荟萃分析和调整后的间接比较
2. Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta‐analysis and adjusted indirect comparison [J] . Loke Yoon K., Pradhan Shiva, Yeong Jessica Ka‐yan, British journal of clinical pharmacology . 2014,第4期

机译：阿哌沙班，利伐沙班和达比加群的比较冠心病风险：一项荟萃分析和调整后的间接比较
3. A comparison of the safety of apixaban, rivaroxaban and dabigatran: an indirect treatment comparison using real-world studies [J] . Alves C., Mendes D., Batel-Marques F. Drug safety: An international journal of medical toxicology and drug experience . 2019,第10期

机译：Apixaban，Rivaroxaban和Dabigatran的安全性比较：使用现实世界研究的间接治疗比较
4. Comparative Analysis of Cardiovascular Risk Profile, Cardiac and Cervical Arterial Ultrasound in Patients with Chronic Coronary and Peripheral Arterial Ischemia [C] . M.A. Stoia, A.D. Farcas, F.P. Anton International Conference on Advancements of Medicine and Health Care through Technology . 2017

机译：慢性冠状动脉患者心血管风险，心肌和宫颈动脉超声的比较分析
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Dabigatran rivaroxaban or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review meta-analysis and indirect treatment comparisons [O] . Antonio Gómez-Outes, Ana Isabel Terleira-Fernández, M Luisa Suárez-Gea, 2012

机译：达比加群利伐沙班或阿哌沙班与依诺肝素联合全髋关节或膝关节置换术后的血栓预防：系统评价荟萃分析和间接治疗比较
7. Comparative coronary risks of apixaban, rivaroxaban and dabigatran:a meta-analysis and adjusted indirect comparison [O] . Loke, Yoon K, Pradhan, Shiva, Yeong, Jessica Ka-Yan, 2014

机译：阿哌沙班，利伐沙班和达比加群的比较冠心病风险：一项荟萃分析和调整后的间接比较

Comparative coronary risks of apixaban rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

摘要

著录项

相似文献

相关主题

期刊订阅